by The global non-PVC IV bags market comprises intravenous (IV) fluid therapy bags manufactured using materials other than polyvinyl chloride (PVC) such as ethyl vinyl acetate (EVA), polyethylene (PE), polypropylene (PP) and copolymers. Non-PVC IV bags are used for delivery of fluids like normal saline, dextrose, Ringer’s lactate and blood/blood components to patients intravenously. They find widespread application in therapeutic areas including general infusion therapy, oncology, acute care, and clinical nutrition. Non-PVC materials offer advantages over PVC including higher stability against radiation and chemicals, optimal gas permeability and compatibility with medications. The growing need for safer and environment-friendly alternatives to conventional PVC IV bags is a major market driver.
Global Non-PVC IV Bags Market is estimated to be valued at US$ 2494.04 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the non-PVC IV bags market are Al Kuwaiti Industrial Solutions, Ziligen A.S., Arabian Universal, Semperit AG Holding, Bridgestone Corporation, Schieffer Magam Industries Ltd., ContiTech AG (Continental AG), Phoenix Conveyor Belt Systems Gmbh, Derby Conveyor Belt Industry and Trade Inc., Kale Conveyor, FaBa Commercial Services, and Fenner Dunlop Conveyor Belting.
The growing demand for IV therapy globally due to rising prevalence of chronic and acute diseases is fueling market growth. Non-PVC IV Bags Market Size offer better stability and compatibility compared to PVC and support accurate dosage delivery.
Key manufacturers are expanding their business globally through partnerships and new product launches to cater to the growing needs of healthcare facilities across regions. For example, Al Kuwaiti Industrial Solutions recently opened a new production facility in Egypt.
Market Key Trends
One of the key trends spurring growth in the non-PVC IV bags market is the shift towards environment-friendly alternatives in healthcare. Stringent regulations restricting the use of PVC in medical products due to concerns over release of dioxins during incineration have created opportunities for non-PVC materials. Emerging bio-based polymers that can be incorporated in IV bags are gaining interest from manufacturers as well as consumers.
Porter’s Analysis
Threat of new entrants: New entrants face high costs to manufacture IV bags with high quality standards set by regulatory bodies. Bargaining power of buyers: Large healthcare providers have significant bargaining power that can lower prices, while individual buyers have limited impact on prices. Bargaining power of suppliers: Suppliers of raw materials like PVC have some bargaining power as materials require technical expertise but many substitutes are available. Threat of new substitutes: New substitute technologies like non-PVC materials pose a challenge but require regulatory clearance and manufacturing changes. Competitive rivalry: The market has many mid-sized players competing on quality, features and price with no player having more than 30% market share.
Geographical Regions
North America accounts for the largest share of the global Non-PVC IV Bags Market in terms of value due to major healthcare infrastructure and expenditure. Rising hospital admissions and use of intravenous solutions is driving regional market growth.
Asia Pacific is the fastest growing regional market for non-PVC IV bags due to increasing healthcare investment, rising medical tourism and growing incidence of chronic diseases in highly populated nations like China and India. Expanding healthcare capacities and focus on quality standards are projected to boost regional demand over the forecast period.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
